2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes

2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes

Abstract Background The management of antidiabetic therapy in people with type 2 diabetes (T2D) has evolved beyond glycemic control. In this context, Brazil and Portugal defined a joint panel of four leading diabetes societies to update the guideline published in 2020. Methods The panelists searched...

Full description

Bibliographic Details
Main Authors: Marcello Casaccia Bertoluci, Wellington S. Silva Júnior, Fernando Valente, Levimar Rocha Araujo, Ruy Lyra, João Jácome de Castro, João Filipe Raposo, Paulo Augusto Carvalho Miranda, Cesar Luiz Boguszewski, Alexandre Hohl, Rui Duarte, João Eduardo Nunes Salles, José Silva-Nunes, Jorge Dores, Miguel Melo, João Roberto de Sá, João Sérgio Neves, Rodrigo Oliveira Moreira, Marcus Vinícius Bolívar Malachias, Rodrigo Nunes Lamounier, Domingos Augusto Malerbi, Luis Eduardo Calliari, Luis Miguel Cardoso, Maria Raquel Carvalho, Hélder José Ferreira, Rita Nortadas, Fábio Rogério Trujilho, Cristiane Bauermann Leitão, José Augusto Rodrigues Simões, Mónica Isabel Natal dos Reis, Pedro Melo, Mafalda Marcelino, Davide Carvalho
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Diabetology & Metabolic Syndrome
Subjects:
ASCVD
Atherosclerotic disease
Cardiovascular risk
Chronic kidney disease
DKD
Diabetes treatment
Online Access:https://doi.org/10.1186/s13098-023-01121-x

Internet

https://doi.org/10.1186/s13098-023-01121-x

Similar Items